0～6月龄婴儿川崎病血清BNP、PCT、IL-6的变化及临床意义

doi:10.3760/cma.j.issn.1007-1245.2022.18.007

国际医药卫生导报 ›› 2022, Vol. 28 ›› Issue (18): 2549-2552.DOI: 10.3760/cma.j.issn.1007-1245.2022.18.007

0～6月龄婴儿川崎病血清BNP、PCT、IL-6的变化及临床意义

谷惠茹

郑州大学附属儿童医院小婴儿科，郑州　450000

收稿日期:2022-02-17 出版日期:2022-09-15 发布日期:2022-10-11
通讯作者: Email：huiru2012@126.com
基金资助:
2022年河南省医学科技攻关联合共建项目（LHGJ20220741）；

2019年度河南省医学科技攻关计划联合共建项目（LHGJ20190905）

Changes and clinical significance of serum BNP, PCT, and IL-6 in infants with Kawasaki disease aged 0-6 months

Gu Huiru

Department of Small Infants, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450000, China

Received:2022-02-17 Online:2022-09-15 Published:2022-10-11
Contact: Email: huiru2012@126.com
Supported by:
Joint Development Project of Henan Province Medical Science and Technology Plan in 2022 (LHGJ20220741);

Joint Development Project of Henan Province Medical Science and Technology Plan in 2019 (LHGJ20190905)

摘要/Abstract

摘要： 目的　研究0～6月龄婴儿川崎病（Kawasaki disease，KD）血清中N末端B型脑钠肽原（NT-proBNP）、降钙素原（PCT）、白细胞介素-6（IL-6）表达水平及临床意义。方法　收集2018年1月1日至2020年12月31日郑州大学附属儿童医院收治KD患儿72例，根据临床表现及体征分为典型组（32例）和不典型组（40例），并选取同期因发热住院治疗非KD患儿为对照组（30例）。典型组患儿男20例，女12例，月龄（2.7±0.2）个月；不典型组患儿男23例，女17例，月龄（2.9±0.1）个月；对照组患儿男17例，女13例，月龄（2.9±0.3）个月。应用电化学发光法检测血清中NT-proBNP水平，应用免疫荧光定量法检测血清中PCT水平，应用酶联免疫吸附法检测血清中IL-6水平。KD患儿使用静注人丙种球蛋白后比较NT-proBNP、IL-6、PCT的变化。采用χ²检验、单因素方差分析、Mann-Whitney U检验、Kruskal-wallis H检验。结果　对照组患儿血清NT-proBNP水平537.25（392.39，724.95）pg/ml低于典型组1 340.00（924.50，3 050.00）pg/ml和不典型组927.90（585.50，1 499.50）pg/ml，差异均有统计学意义（均P<0.05），典型组和不典型组相比差异无统计学意义（P>0.05）。对照组患儿血清IL-6水平24.90（14.75，33.13）pg/ml低于典型组98.07（83.56，151.15）pg/ml和不典型组72.28（55.35，114.30）pg/ml，差异均有统计学意义（均P<0.05），典型组和不典型组相比差异无统计学意义（P>0.05）。对照组患儿PCT水平0.96（0.55，2.13）μg/L与不典型组0.24（0.14，0.50）μg/L、典型组0.40（0.29，0.74）μg/L比较，差异均有统计学意义（均P<0.05）。治疗后KD患儿NT-proBNP、IL-6水平较治疗前NT-proBNP、IL-6下降［365.10（205.73，736.35）pg/ml比1 168.50（773.95，1 972.25）pg/ml，15.55（5.83，46.32）pg/ml比91.70（69.24，136.67）pg/ml］，差异均有统计学意义（均P<0.05）；治疗后患儿PCT水平与治疗前比较差异无统计学意义［0.12（0.07，0.25）μg/L比0.33（0.17，0.58）μg/L］（P>0.05）。结论　NT-proBNP、IL-6、PCT疾病前期联合检测可作为辅助诊断0～6月龄小婴儿KD的重要参考指标。

关键词: N末端脑钠肽前体, 白细胞介素-6, 降钙素原, 川崎病

Abstract: Objective　To study the expression levels of N-terminal B-type brain natriuretic peptide (NT-proBNP), procalcitonin (PCT), and interleukin-6 (IL-6) in serum of 0-6 months old infants with Kawasaki disease (KD) and their clinical significance. Methods　A total of 72 children with KD hospitalized in Children's Hospital Affiliated to Zhengzhou University from January 1, 2018 to December 31, 2020 were selected and were divided into a typical group (32 cases) and an atypical group (40 cases) according to the clinical manifestations and signs. And 30 non-KD children hospitalized with fever during the same period were selected as a control group. The level of NT-proBNP in serum was determined by electrochemiluminescence method, the level of PCT in serum was determined by immunofluorescence quantitative method, and the level of IL-6 in serum was determined by enzyme-linked immunosorbent assay. The changes of NT-proBNP, IL-6, and PCT in KD children were observed after intravenous injection of human gamma globulin. χ² test, one-way analysis of variance, Mann-Whitney U test, and Kruskal-Wallis H test were used. Results　The level of serum NT-proBNP in the control group was 537.25 (392.39, 724.95) pg/ml, which was lower than those in the typical group and the atypical group [1 340.00 (924.50, 3 050.00) pg/ml and 927.90 (585.50, 1 499.50) pg/ml], with statistically significant differences (both P<0.05), but there was no statistically significant difference between the typical group and the atypical group (P>0.05). The level of serum IL-6 in the control group was 24.90 (14.75, 33.13) pg/ml, which was lower than those in the typical group and the atypical group [98.07 (83.56, 151.15) pg/ml and 72.28 (55.35, 114.30) pg/ml], with statistically significant differences (both P<0.05), but there was no statistically significant difference between the typical group and the atypical group (P>0.05). There were statistically significant differences in the PCT level among the control group [0.96 (0.55, 2.13) μg/L], the atypical group [(0.24 (0.14, 0.50) μg/L], and the typical group [0.40 (0.29, 0.74) μg/L], with statistically significant differences (all P<0.05). After treatment, the levels of NT-proBNP and IL-6 in children with KD decreased compared with those before treatment [365.10 (205.73, 736.35) pg/ml vs. 1 168.50 (773.95, 1 972.25) pg/ml, 15.55 (5.83, 46.32) pg/ml vs. 91.70 (69.24, 136.67) pg/ml], with statistically significant differences (both P<0.05). There was no statistically significant difference in the level of PCT between before and after treatment [0.12 (0.07, 0.25) μg/L vs. 0.33 (0.17, 0.58) μg/L] (P>0.05). Conclusion　NT-proBNP, IL-6, and PCT can be used as important reference indexes for the diagnosis of KD in infants aged 0-6 months in the early stage of the disease.

Key words: N-terminal brain natriuretic peptide precursor, Interleukin-6, Procalcitonin, Kawasaki disease

谷惠茹. 0～6月龄婴儿川崎病血清BNP、PCT、IL-6的变化及临床意义[J]. 国际医药卫生导报, 2022, 28(18): 2549-2552.

Gu Huiru. Changes and clinical significance of serum BNP, PCT, and IL-6 in infants with Kawasaki disease aged 0-6 months[J]. International Medicine and Health Guidance News, 2022, 28(18): 2549-2552.

参考文献

[1] Agarwal S, Agrawal DK. Kawasaki disease: etiopathogenesis and novel treatment strategies[J]. Expert Rev Clin Immunol, 2017, 13(3):247-258. DOI: 10.1080/1744666X.2017.1232165.
[2] Singh S, Vignesh P, Burgner D. The epidemiology of Kawasaki disease: a global update[J]. Arch Dis Child, 2015, 100(11):1084-1088. DOI: 10.1136/archdischild- 2014-307536.
[3] McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association[J]. Circulation, 2017, 135(17):e927-e999. DOI: 10.1161/CIR.0000000000000484.
[4] Del Principe D, Pietraforte D, Gambardella L, et al. Pathogenetic determinants in Kawasaki disease: the haematological point of view[J]. J Cell Mol Med, 2017, 21(4):632-639. DOI: 10.1111/jcmm.12992.
[5] 王金菊,陈宗波,王文棣.川崎病患儿心型脂肪酸结合蛋白和脑利钠肽的变化及与心功能的关系[J].中国小儿急救医学,2015,22(4):273-275. DOI:10.3760/cma.j.issn.1673- 4912.2015.04.015.
[6] 赵梦雅,段美丽.血乳酸和乳酸清除率与降钙素原联合检测对脓毒症患者病情严重程度及预后评估的临床意义[J].中华危重病急救医学,2020,32(4):449-453. DOI:10.3760/cma.j.cn121430-20200129-00086.
[7] Ritchie B, Porritt K, Marin T, et al. Diagnostic test accuracy of serum measurement of procalcitonin and C-reactive protein for bone and joint infection in children and adolescents: a systematic review protocol[J]. JBI Evid Synth, 2020, 18(3):564-570. DOI: 10.11124/JBISRIR- D-19-00139.
[8] Dietz SM, van Stijn D, Burgner D, et al. Dissecting Kawasaki disease: a state-of-the-art review[J]. Eur J Pediatr, 2017, 176(8):995-1009. DOI: 10.1007/s00431-017-2937-5.
[9] Yılmazer MM, Öner T, Gökalp S, et al. Risk factors for persistence of coronary artery abnormalities in Turkish children with Kawasaki disease[J]. Turk J Pediatr, 2015, 57(3):248-253.
[10] Marti CN, Khan H, Mann DL, et al. Soluble tumor necrosis factor receptors and heart failure risk in older adults: Health, Aging, and Body Composition (Health ABC) Study[J]. Circ Heart Fail, 2014, 7(1):5-11. DOI: 10.1161/CIRCHEARTFAILURE.113.000344.
[11] 叶晓春,张静.不同评分体系对重庆地区静脉丙种球蛋白无反应川崎病预测能效评价[J].中国循证儿科杂志,2016,11(5):337-340. DOI:10.3969/j.issn.1673-5501.2016. 05.004.
[12] 任磊,刘霞,周启立,等.血清降钙素原和C反应蛋白对支气管哮喘急性发作患儿细菌性感染的诊断价值[J].临床和实验医学杂志,2015,14(21):1796-1798. DOI:10.3969/j.issn.1671-4695.2015.21.016.

0～6月龄婴儿川崎病血清BNP、PCT、IL-6的变化及临床意义

Changes and clinical significance of serum BNP, PCT, and IL-6 in infants with Kawasaki disease aged 0-6 months

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 6

编辑推荐

Metrics

[1]	邓诗月, 吕翔, 蒋丽军. 视频脑电图联合外周血炎症指标在早产儿脑损伤诊断中的应用[J]. 国际医药卫生导报, 2022, 28(6): 832-836.
[2]	赖呈哲. 急性心力衰竭患者血清cTnI、NT-proBNP、尿酸水平与预后的关系分析[J]. 国际医药卫生导报, 2022, 28(17): 2465-2470.
[3]	余锦旗　何伟　林倩倩　陈颖婷　欧财文　宋丽婷. 基蛋Getein 1600干式免疫荧光法检测降钙素原的性能验证[J]. 国际医药卫生导报, 2022, 28(15): 2098-2100.
[4]	郭润静, 郝东. 脓毒症相关生物标志物及作用机制研究进展[J]. 国际医药卫生导报, 2022, 28(10): 1468-1471.
[5]	渠吉皊, 沈易静, 侯苹, 周婷, 李永男, 冒鑫娥, 刘永兵. 白细胞介素-6与衰弱的相关性meta分析[J]. 国际医药卫生导报, 2021, 27(6): 802-806.
[6]	杨小娟, 李晓东. IL-6及SAA在新生儿败血症早期诊断中的应用[J]. 国际医药卫生导报, 2021, 27(6): 848-851.